NCT00087217View on ClinicalTrials.gov

17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

tanespimycin

Given IV

DRUG

paclitaxel

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

19104

University of Pennsylvania Medical Center, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00087217 - 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor | Biotech Hunter | Biotech Hunter